Miyauchi J, Wang C, Kelleher C A, Wong G G, Clark S C, Minden M D, McCulloch E A
Ontario Cancer Institute, Toronto, Canada.
J Cell Physiol. 1988 Apr;135(1):55-62. doi: 10.1002/jcp.1041350108.
Recombinant hemopoietic colony-stimulating factors (CSFs), including GM-CSF, G-CSF and IL-3, have been shown to be effective stimulators of both self-renewal and terminal differentiation of blast stem cells in acute myeloblastic leukemia (AML). We have examined the activity of a fourth growth factor, recombinant CSF-1 (or M-CSF), on the growth of leukemic blasts in culture. CSF-1 was found to be active on some, but not all, blast populations. In sensitive cells, CSF-1 often stimulated the production of adherent blast cells incapable of division. This observation leads us to suggest that CSF-1 may be useful in the treatment of selected cases of AML.
重组造血集落刺激因子(CSFs),包括粒细胞-巨噬细胞集落刺激因子(GM-CSF)、粒细胞集落刺激因子(G-CSF)和白细胞介素-3(IL-3),已被证明是急性髓性白血病(AML)中原始干细胞自我更新和终末分化的有效刺激剂。我们已经研究了第四种生长因子,重组集落刺激因子-1(CSF-1,或巨噬细胞集落刺激因子(M-CSF))对培养的白血病原始细胞生长的活性。发现CSF-1对部分而非全部原始细胞群体有活性。在敏感细胞中,CSF-1常常刺激产生不能分裂的贴壁原始细胞。这一观察结果使我们认为CSF-1可能对某些AML病例的治疗有用。